| Financial Year |
March 31 2023 |
| Monetary Funds |
2,214,555,137.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
541,411,494.00 |
| Accounts Receivable |
1,696,421,712.00 |
| Advances to Suppliers |
210,842,851.00 |
| Other Receivables |
186,479,334.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,042,154,149.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
40,000,000.00 |
| Other Current Assets |
188,123,840.00 |
| Total Current Assets |
8,036,264,934.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
290,368,105.00 |
| Fixed Assetes |
12,548,990,547.00 |
| Under-construction Projects |
1,656,976,274.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,475,500,214.00 |
| R&D expenses |
51,791,445.00 |
| Goodwill |
8,593,352.00 |
| Long-Term Deferred and Prepaid Expenses |
5,860,172.00 |
| Deferred Income Tax Assets |
161,384,629.00 |
| Other Non-Current Assets |
1,391,600,313.00 |
| Sub-Total of Non-Current Assets |
17,600,813,228.00 |
| Total Assets |
25,637,078,162.00 |
| Short-Term Loans |
475,796,035.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,222,172,076.00 |
| Accounts Payable |
2,443,169,032.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
252,299,141.00 |
| Taxes Payable |
178,935,981.00 |
| Interest Payable |
10,028,889.00 |
| Dividend Payable |
-- |
| Other payables |
446,054,915.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
621,683,133.00 |
| Other Current Liabilities |
43,680,585.00 |
| Sub-Total of Current Liabilities |
6,041,615,999.00 |
| Long-term Loans |
5,184,512,865.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
107,669,051.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
96,757,064.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,829,165,411.00 |
| Total Liabilities |
11,870,781,410.00 |
| Paid-In Capital(Or Share Stock) |
3,070,692,107.00 |
| Capital Surplus |
596,997,085.00 |
| Surplus Reserve |
1,228,634,001.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,183,374,542.00 |
| Minority Stockholder's Interest |
516,840,866.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,249,455,886.00 |
| Owner's Equity（Stockholder's Equity） |
13,766,296,752.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
25,637,078,162.00 |
